Shuan Rao
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research 4
- Cancer Research top 5%
- Neurology top 2%
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 4
- RNA modifications and cancer 4
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 7
- Cancer Immunotherapy and Biomarkers 4
-
- Gastric Cancer Management and Outcomes 6
-
- Muscle metabolism and nutrition 5
-
- Esophageal Cancer Research and Treatment 4
- Co-authors
- Chengyu JiangJosef PenningerFeng GuoKeiji KubaYumiko ImaiXiaozhong PengYi HuanMichael A. Crackower
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Shuan Rao
47 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Infectious Diseases 1.5k
- Cancer Research 563
- Neurology 517
- Molecular Biology 1.5k
- Oncology 465
Countries citing papers authored by Shuan Rao
This map shows the geographic impact of Shuan Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuan Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuan Rao more than expected).
Fields of papers citing papers by Shuan Rao
This network shows the impact of papers produced by Shuan Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuan Rao. The network helps show where Shuan Rao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shuan Rao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 25 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 21 | |
| 9 | 2022 | 2 | |
| 10 | 2021 | 8 | |
| 11 | The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translationbreakdown → | 2020 | 530 |
| 12 | 2020 | 119 | |
| 13 | 2019 | 28 | |
| 14 | 2017 | 1 | |
| 15 | 2017 | 65 | |
| 16 | 2014 | 53 | |
| 17 | 2006 | 11 | |
| 18 | 2001 | 8 | |
| 19 | 2000 | 21 | |
| 20 | 1974 | 2 |
About Shuan Rao
Shuan Rao is a scholar working on Oncology, Complementary and alternative medicine and Orthopedics and Sports Medicine, having authored 50 papers that have together received 3.9k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (7 papers), Gastric Cancer Management and Outcomes (6 papers), Muscle metabolism and nutrition (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Esophageal Cancer Research and Treatment (4 papers), Epigenetics and DNA Methylation (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Infectious Diseases (1.5k citations), Cancer Research (563 citations) and Neurology (517 citations). Shuan Rao has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Chengyu Jiang, Josef Penninger, Feng Guo, Keiji Kuba, Yumiko Imai, Xiaozhong Peng, Yi Huan, Michael A. Crackower, Renu Sarao and Teiji Wada. Their work appears in journals such as Nature, Nucleic Acids Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.